The store will not work correctly when cookies are disabled.
Potassium 3-((3-aminophenyl)amino)quinoxaline-2-carboxylate
ID: ALA4174068
PubChem CID: 145951035
Max Phase: Preclinical
Molecular Formula: C15H11KN4O2
Molecular Weight: 280.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1cccc(Nc2nc3ccccc3nc2C(=O)[O-])c1.[K+]
Standard InChI: InChI=1S/C15H12N4O2.K/c16-9-4-3-5-10(8-9)17-14-13(15(20)21)18-11-6-1-2-7-12(11)19-14;/h1-8H,16H2,(H,17,19)(H,20,21);/q;+1/p-1
Standard InChI Key: CUEALKAWATXLFP-UHFFFAOYSA-M
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
27.7515 -2.8478 0.0000 K 0 0 0 0 0 15 0 0 0 0 0 0
22.8552 -4.1520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8540 -4.9715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5621 -5.3805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5603 -3.7431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2689 -4.1484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2697 -4.9674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9782 -5.3744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6865 -4.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6817 -4.1415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9726 -3.7381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3958 -5.3695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3869 -3.7286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0971 -4.1329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3820 -2.9114 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.3989 -6.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6934 -6.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6962 -7.4095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4061 -7.8162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1145 -7.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1082 -6.5854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8252 -7.8038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
9 12 1 0
10 13 1 0
13 14 2 0
13 15 1 0
12 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
M CHG 2 1 1 15 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 280.29 | Molecular Weight (Monoisotopic): 280.0960 | AlogP: 2.65 | #Rotatable Bonds: 3 |
Polar Surface Area: 101.13 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.38 | CX Basic pKa: 4.58 | CX LogP: 2.54 | CX LogD: 0.46 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.64 | Np Likeness Score: -0.92 |
References
1. Oyallon B, Brachet-Botineau M, Logé C, Bonnet P, Souab M, Robert T, Ruchaud S, Bach S, Berthelot P, Gouilleux F, Viaud-Massuard MC, Denevault-Sabourin C.. (2018) Structure-based design of novel quinoxaline-2-carboxylic acids and analogues as Pim-1 inhibitors., 154 [PMID:29778892] [10.1016/j.ejmech.2018.04.056] |